| Alberman, E. & Mutch, L. Commentary on the revised versions of the definition and classification of cerebral palsy, Dev.Med.Child Neurol.Suppl, vol. 109, p. 32. |
| Barnes, I. M., Bestwick, J. P., & Larsen, S. O. Setting truncation limits for marker values in medical screening, J.Med.Screen., vol. 14, no. 2, pp. 103-106. |
| Bayston, R., Russell, A., Wald, N. J., & Hoffbrand, A. V. Folic acid fortification and cancer risk, Lancet, vol. 370, no. 9604, p. 2004. |
| Carnes, D., Parsons, S., Ashby, D., Breen, A., Foster, N. E., Pincus, T., Vogel, S., & Underwood, M. Chronic musculoskeletal pain rarely presents in a single body site: results from a UK population study, Rheumatology.(Oxford), vol. 46, no. 7, pp. 1168-1170. |
| Crane, E. & Morris, J. K. Paternal age and birth defects: how strong is the association, Hum.Reprod., vol. 22, no. 8, pp. 2349-2350. |
| Dickinson, C. J. Intracerebral haemorrhage revisited, QJM., vol. 100, no. 11, pp. 715-719. |
| Dickinson, C. J. Invited editorial: 'Essential hypertension: is it all in the brain?' in 'Hypertension: Cross-Talk Between
the Brain and Other Organs', Dialog Cardiovasc Med, vol. 12, no. 3, pp. 159-161. |
| Dickinson, C. J. What can clinical medicine give back to physiology?, Physiol News no. 66, pp. 18-20. |
| Hajek, P., McRobbie, H., & Gillison, F. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user, Prev.Med, vol. 44, no. 3, pp. 230-234. |
| Lamb, S. E., Gates, S., Underwood, M. R., Cooke, M. W., Ashby, D., Szczepura, A., Williams, M. A., Williamson, E. M., Withers, E. J., Mt, I. S., & Gumber, A. Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disorders, BMC.Musculoskelet.Disord., vol. 8, p. 7. |
| Law, M. R., Morris, J. K., & Wald, N. J. Calcium channel blockers and headache, Br.J.Clin.Pharmacol., vol. 63, no. 2, pp. 157-158. |
| MacCallum, P., Madhani, M., Mt-Isa, S., & Ashby, D. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin, Pharmacoepidemiol.Drug Saf, vol. 16, no. 7, pp. 786-789. |
| Marlow, N., Hennessy, E. M., Bracewell, M. A., & Wolke, D. Motor and executive function at 6 years of age after extremely preterm birth, Pediatrics, vol. 120, no. 4, pp. 793-804. |
| McRobbie, H. & Hajek, P. Effects of rapid smoking on post-cessation urges to smoke, Addiction, vol. 102, no. 3, pp. 483-489. |
| Morris, J. K. & Wald, N. J. The effect of correlations between screening markers on screening performance, J.Med Screen, vol. 14, no. 3, pp. 151-157. |
| Morris, J. K. & Wald, N. J. Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004, J.Med Screen., vol. 14, no. 2, pp. 55-59. |
| Morris, J. K. & Wald, N. J. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies, J.Med Screen., vol. 14, no. 1, pp. 5-7. |
| Paton, J. F., Waki, H., Abdala, A. P., Dickinson, J., & Kasparov, S. Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide, Curr.Hypertens.Rep., vol. 9, no. 3, pp. 242-247. |
| Wald, D. S. Problems with performance related pay in primary care, BMJ, vol. 335, no. 7619, p. 523. |
| Wald, D. S. The future of coronary heart disease prevention, Clin.Med, vol. 7, no. 4, pp. 392-396. |
| Wald, D. S., Bestwick, J. P., & Wald, N. J. Familial hypercholesterolaemia: screening needs a fresh approach, BMJ, vol. 335, no. 7628, pp. 1007-1008. |
| Wald, D. S., Bestwick, J. P., & Wald, N. J. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis, BMJ, vol. 335, no. 7620, p. 599. |
| Wald, D. S., Morton, G., Walker, K., Iosson, N., & Curzen, N. P. Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease, Ann.Pharmacother., vol. 41, no. 10, pp. 1644-1647. |
| Wald, N. Neonatal screening: old dogma or sound principle?, Pediatrics, vol. 119, no. 2, pp. 406-407. |
| Wald, N. Paying for publication, J.Med Screen., vol. 14, no. 1, p. 1. |
| Wald, N. J. Screening: a step too far. A matter of concern, J.Med Screen., vol. 14, no. 4, pp. 163-164. |
| Wald, N. J. & Oakley, G. P. Should folic acid fortification be mandatory? Yes, BMJ, vol. 334, no. 7606, p. 1252. |
| Wald, N. J., Bestwick, J. P., Barnes, I. M., & Kellner, L. H. Anomalous marker patterns in Down syndrome screening, Prenat.Diagn., vol. 27, no. 2, pp. 185-186. |
| Wald, N. J., Bestwick, J. P., & Morris, J. K. Truncation limits for CT marker ratios in prenatal screening for Down syndrome, Prenat.Diagn., vol. 27, no. 2, pp. 187-188. |
| Weisz, B., Pandya, P. P., David, A. L., Huttly, W., Jones, P., & Rodeck, C. H. Ultrasound findings after screening for Down syndrome using the integrated test, Obstet.Gynecol., vol. 109, no. 5, pp. 1046-1052. |
| Weisz, B., Pandya, P., Chitty, L., Jones, P., Huttly, W., & Rodeck, C. Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice, BJOG., vol. 114, no. 4, pp. 493-497. |
|
